The portfolio rose, but no new evidence or risk limit requires chasing or cutting exposure.
ACIS RESEARCHPERSONALIZED RESEARCHContact ACIS ↗PERSONALIZED PORTFOLIO RESEARCH · SAMPLE
From risk profile
to a weekly decision.
This fictional example shows what a client receives: a clear decision status, the evidence behind it, portfolio risks and the next conditions to verify.
Every person, amount, holding, trade and result on this page is fictional. It demonstrates the report structure only, does not represent a real client or track record, and is not personalized investment advice.
10-SECOND ANSWER
The client decision board
A report should answer what to do, why, and what could change the answer.
Core beta and compounders, supported by bonds, gold and cash.
QQQ, Microsoft and Google can behave like one factor when sentiment reverses.
Verify whether AI capital spending continues to convert into revenue and free cash flow.
FICTIONAL CLIENT PROFILE
P2 · Balanced investor
A representative personal-investor case: medium risk capacity, medium risk willingness, a 5–10 year horizon and a need for both growth and resilience.
- Simulated capital
- US$1,000,000
- Single-stock limit
- 12%
- Weekly turnover limit
- 8%
- Liquidity baseline
- 10% Cash
ORIGINAL PORTFOLIO · BEFORE ACIS REVIEW
What did the client already own?
This fictional P2 portfolio was locked on 16 September 2026 before the ACIS review. It is the diagnostic starting point and the Buy & Hold baseline—not a portfolio reconstructed with hindsight.
Every holding and weight above is fictional test data. It demonstrates the research process only, does not correspond to a real client and is not an allocation recommendation.
EVIDENCE TIMELINE
From the W0 baseline to the first weekly check
Baseline established
Locked the original holdings, simulated starting value of US$1,000,000 and portfolio constraints. Established three paths: Original Buy & Hold, risk-matched policy benchmark and ACIS simulated portfolio. No rebalance was made; returns, costs and turnover started at zero.
First valid weekly observation
Original portfolio +1.68%; policy benchmark +1.28%; ACIS simulated portfolio +1.68%. Weekly action: No Action. Risk status: continued Review. Turnover: 0%.
Why are the Original and ACIS results the same? The adjustment threshold was not met, so ACIS did not trade merely to create a difference. No Action is still a documented, evidence-based decision.
One valid weekly observation tests the process; it does not establish long-term investment skill or predict future results.
WHAT → SO WHAT → NOW WHAT
How evidence becomes a decision
What changed?
Growth assets rose. Microsoft increased its quarterly dividend. No holding breached the portfolio's hard constraints.
What does it mean?
Cash-flow quality remains supportive, but one week of price strength does not improve the investor's risk capacity or justify a higher equity budget.
What should happen now?
Keep the allocation unchanged. Continue to review concentration, long rates and AI earnings conversion. Do not chase.
THESIS → EVIDENCE → UPDATE
A sample thesis card
Microsoft
A core compounder whose AI investment must be supported by durable cash flow and distribution.
Dividend increased
The quarterly dividend rose from US$0.91 to US$0.98. That supports cash-flow quality, but does not by itself prove the return on AI spending.
Thesis unchanged
Keep as a core holding. The evidence is supportive, not a standalone reason to add after a price rise.
SIMULATED MEASUREMENT
Comparison, with the boundary attached
One effective weekly observation is not a track record. These figures only demonstrate how the report compares three paths after costs and public distributions.
No action is itself a decision. The sample does not use leverage, short selling or options, and no real transaction was executed.
NEXT 90 DAYS
What the next report will verify
The report changes only when evidence or the client's own circumstances change.
- 01AI earnings conversionRevenue, margins and free cash flow versus capital spending.
- 02Factor concentrationWhether QQQ, Microsoft and Google create more overlap than headline weights suggest.
- 03Long-rate riskInflation, term premium and the defensive role of IEF.
- 04Client conditionsAny change in cash needs, time horizon, liabilities or loss capacity.
SAME MARKET · DIFFERENT CLIENTS
Why one signal does not create one answer
The research evidence can be shared. The decision must still respect each client's capacity, willingness, horizon and existing exposures.
From cash to a portfolio
Entry pacing and risk budget
Conservative defense
Liquidity, drawdown and defense
Balanced
Growth, defense and portfolio health
Long-term growth
Structural growth and alpha limits
High-volatility concentrated
Concentration, correlation and de-risking
DECISION LANGUAGE
Four levels—not a constant stream of trades
The purpose is to separate information, review and actual decision escalation.
No Action
No new evidence or constraint requires a portfolio change.
Review
A change deserves review but has not reached an adjustment threshold.
Rebalance Discussion
An adjustment should be discussed and still requires client confirmation.
Simulated Rebalance
Recorded only when public evidence, portfolio constraints and preset rules all align.
QUESTIONS & BOUNDARIES
What this sample is—and is not
Is this a real client account?
No. Every identity, amount, holding and result is fictional and used only to demonstrate the workflow.
Does ACIS trade automatically?
No. The sample records research decisions and simulated rebalances. Real actions require the client's own confirmation and appropriate regulated execution arrangements.
Can clients choose stocks and indicators?
Yes. The research universe, personal constraints, evidence thresholds and dashboard fields can be configured around the agreed scope.
Do simulated returns predict future results?
No. They are process-testing data, not a performance promise. Tax, spreads, liquidity and real execution can create materially different outcomes.
FROM SAMPLE TO YOUR QUESTIONS
The value is not another dashboard. It is a decision system that remembers.
Start with risk, objectives and existing exposures. Then decide what deserves monitoring and what evidence should change the view.